Efficacy and Tolerability of Escitalopram in Treatment of Major Depressive Disorder With Anxiety Symptoms: A 24-Week, Open-Label, Prospective Study in Chinese Population

Neuropsychiatric Disease and Treatment
doi 10.2147/ndt.s120190
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Efficacy, Safety and Tolerability of Escitalopram in Doses Up to 50 Mg in Major Depressive Disorder (MDD): An Open-Label, Pilot Study

BMC Psychiatry
PsychiatryMental Health
2011English

Erratum To: Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results From an Open-Label, 48-Week Extension Study

Clinical Drug Investigation
MedicinePharmacology
2013English

Efficacy and Tolerability of Mirtazapine Versus Paroxetine in the Treatment of Major Depressive Disorder

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2012English

Safety, Tolerability, and Efficacy of Vortioxetine (Lu AA21004) in Major Depressive Disorder

International Clinical Psychopharmacology
PsychiatryMental HealthPharmacology
2014English

Efficacy and Tolerability of Carbamazepine for the Treatment of Painful Diabetic Neuropathy in Adults: A 12-Week, Open-Label, Multicenter Study

International Journal of General Medicine
Medicine
2014English

Role of Vitamin D Supplementation as Adjunctive Therapy to Escitalopram in Patients of Major Depressive Disorder: A 8 Week Prospective, Randomized, Interventional, Clinical Study

International Journal of Basic & Clinical Pharmacology
2019English

Aripiprazole in Pervasive Developmental Disorder Not Otherwise Specified and Asperger's Disorder: A 14-Week, Prospective, Open-Label Study

Journal of Child and Adolescent Psychopharmacology
Mental HealthChild HealthPharmacologyPerinatologyPsychiatryPediatrics
2009English

Efficacy of Brexpiprazole as Adjunctive Treatment in Major Depressive Disorder With Irritability

Journal of Clinical Psychopharmacology
PsychiatryMental HealthPharmacology
2017English

Escitalopram vs Duloxetine in Acute Treatment of Major Depressive Disorder: Meta-Analysis and Systematic Review

Neuropsychiatric Disease and Treatment
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy